肌腱蛋白C(TNC)重組蛋白
Recombinant Tenascin C (TNC)
TN-C; HXB; TN; GMEM; JI; Myotendinous antigen; Neuronectin; GP 150-225; Cytotactin; Hexabrachion; Glioma-associated-extracellular matrix antigen
- 編號(hào)RPB975Hu02
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
- 亞細(xì)胞定位細(xì)胞外基質(zhì)
- 預(yù)測(cè)分子量36.9kDa
- 實(shí)際分子量40kDa(差異分析請(qǐng)參閱說明書)
- 片段與標(biāo)簽Leu1262~Ser1566 with N-terminal His Tag
- 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)4.3
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價(jià)格 ¥ 1003 ¥ 2508 ¥ 5016 ¥ 15048 ¥ 37620
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPB975Hu02 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB975Hu01 | 肌腱蛋白C(TNC)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB975Hu01 | 肌腱蛋白C(TNC)多克隆抗體 | WB; IHC; ICC; IP. |
PAB975Hu02 | 肌腱蛋白C(TNC)多克隆抗體 | WB; IHC; ICC; IP. |
LAB975Hu71 | 肌腱蛋白C(TNC)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAB975Hu22 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
MAB975Hu21 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
MAB975Hu23 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
MAB975Hu24 | 肌腱蛋白C(TNC)單克隆抗體 | WB; IHC; ICC; IP. |
SEB975Hu | 肌腱蛋白C(TNC)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB975Hu | 肌腱蛋白C(TNC)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Medical Principles and Practice | An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty [Pubmed: 22889719] |
Tumor Biology | Clinical significance of serum tenascin-c levels in epithelial ovarian cancer [Springer: Source] |
Tumor Biology | Clinical significance of serum tenascin-C levels in breast cancer [Springer: Source] |
BioFactors | Tenascin-C is increased in atherothrombotic stroke patients and has an anti-inflammatory effect in the human carotid artery. [Pubmed:24823872] |
Connective Tissue Research | Metabolic and cytoprotective effects of in vivo peri-patellar hyaluronic acid injections in cultured tenocytes [Pubmed:25333747] |
K | Role of Tenascin-C in the differential diagnosis of small round blue cell tumors [Index.Php: Sdutfd] |
Life Sci | A new predictor of mortality in hemodialysis patients; Tenascin-C [PubMed: 26390818] |
Heart Research | Biomarkers Score for Patients with Mitral Stenosis: A useful conjunction with Wilkins’s Score for Early Intervention [Heartresearchopenjournal: Hroj5] |
Ara?t?rmalar / Researches | Pankreas Adenokarsinomunda Serum Tenascin-C Düzeyi Potansiyel Bir Biyobelirte? Midir? [Cpdf:5C21620161255] |
Archives of Dermatological Research | Increased tenascin C and DKK1 in vitiligo: possible role of fibroblasts in acral and non-acral disease [Pubmed:29605863] |
Methods?in?Cell?Biology | How to detect and purify tenascin-C [Pubmed:29310788] |
Scientific Reports | Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion [Pubmed: 31358880] |
留言咨詢